According to Genetic Technologies's latest financial reports the company's current earnings (TTM) are -$3.8 M. In 2023 the company made an earning of -$7.89 M a decrease over its 2022 earnings that were of -$4.93 M.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 | -$7.89 M | 59.96% |
2022 | -$4.93 M | -7.32% |
2021 | -$5.32 M | 22.94% |
2020 | -$4.33 M | -4.15% |
2019 | -$4.52 M | 11.64% |
2018 | -$4.05 M | -37.41% |
2017 | -$6.46 M | 2.21% |
2016 | -$6.32 M | -6.53% |
2015 | -$6.76 M | -29.17% |
2014 | -$9.55 M | 11.82% |
2013 | -$8.54 M | 57.37% |
2012 | -$5.43 M | -676.53% |
2011 | $0.94 M | -111.41% |
2010 | -$8.25 M | 24.16% |
2009 | -$6.65 M | 26.89% |
2008 | -$5.24 M | 324.26% |
2007 | -$1.24 M | -68.76% |
2006 | -$3.95 M | -16.29% |
2005 | -$4.72 M | 6.06% |
2004 | -$4.45 M | 476.13% |
2003 | -$0.78 M | -86.69% |
2002 | -$5.8 M | 158.11% |
2001 | -$2.25 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Thermo Fisher Scientific TMO | $6.29 B | -166,082.32% | ๐บ๐ธ USA |
Quest Diagnostics
DGX | $1.13 B | -29,880.89% | ๐บ๐ธ USA |
Danaher DHR | $5.33 B | -140,570.91% | ๐บ๐ธ USA |
LabCorp LH | $0.77 B | -20,498.59% | ๐บ๐ธ USA |
Compugen CGEN | -$9.79 M | 157.86% | ๐ฎ๐ฑ Israel |
Neogen NEOG | -$0.26 M | -93.25% | ๐บ๐ธ USA |
Myriad Genetics MYGN | -$0.26 B | 6,733.79% | ๐บ๐ธ USA |
Eterna Therapeutics ERNA | -$20.53 M | 440.83% | ๐บ๐ธ USA |